Medical Oncology

Chronic kidney disease

Questions discussed in this category

How do you approach patients who are inappropriately worried/fixated on a test result that is flagged as abnormal but not clinically significant?

(i.e., isolated elevation in MCHC, RDW.) Especially when all other lab results are normal and reassuring.

4 Answers available

Do you have a higher threshold regarding when to hold bevacizumab for proteinuria in patients who had known baseline proteinuria from diabetic nephropathy?

2 Answers available

Would you recommend use of ESA for anemia of kidney disease in the setting of metastatic solid tumor malignancy?

1 Answer available

How would you approach immunosuppression for patients with severe aplastic anemia who are not transplant or ATG candidates?

Such as patients who are frail, elderly, renally impaired? Would you consider sirolimus over cyclosporine or tacrolimus for safer nephrotoxicity prof...

1 Answer available

Papers discussed in this category

Am J Kidney Dis, 2019 Aug 05

The Use of Erythropoiesis-Stimulating Agents in Patients With CKD and Cancer: A Clinical Approach.

Medical Oncology

Chronic kidney disease

Questions discussed in this category

Papers discussed in this category

Related Topics in Medical Oncology